; (3) an analysis of the risk to the Government in providing the Federal guarantee described under section 4(b); (4) any recommended improvements to the BioBonds Program; and (5) any other matter that the Comptroller General or the Secretary, respectively, determines is appropriate. 7. Authorization of appropriations (a) In general There is authorized to be appropriated to the Secretary of the Treasury to pay for the cost of guaranteeing BioBonds under this Act $10,000,000,000 for each of fiscal years 2025, 2026, and 2027. (b) Program funding (1) Administrative expenses paid from bond sales Except as provided under paragraph (2), the cost of carrying out this Act, including the cost to the Secretary of the Treasury in administering the BioBond Program, shall be recovered from the proceeds from the sale of BioBonds or from fees as set forth in paragraph (3). (2) Specific appropriation or contribution No guarantee shall be made under this Act unless— (A) an appropriation for the full cost of the guarantee has been made; (B) the Secretary has received from the BioBond issuer a payment in full for the cost of the guarantee; or (C) a combination of an appropriation and the deposit of a payment from the BioBond issuer has been made in a sufficient amount to cover the full cost of the guarantee. (3) Guarantee fees The Secretary of the Treasury shall charge and collect fees for guarantees under this Act in amounts the Secretary determines are sufficient to recover applicable administrative expenses, and such fees— (A) shall be available to the Secretary, without further appropriation, to pay for the administrative expenses related to guarantees under this Act